1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
  3. CXCR
  4. CXCR Inhibitors

CXCR Inhibitors

CXCR

CXCR1

CXCR2

CXCR3

CXCR4

CXCR7

CXCR6

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

CXCR Inhibitors, Agonists, Antagonists, Activators & Modulators
Product Name CXCR CXCR1 CXCR2 CXCR3 CXCR4 CXCR7 CXCR6 Purity
Plerixafor        
125I-CXCL12-CXCR4, IC50: 44 nM
    99.90%
SB225002    
125I-IL-8-CXCR2, IC50: 22 nM (in CHO cell membrane)
        99.87%
AMG 487      
125I-IP10-CXCR3, IC50: 8 nM
125I-ITAC-CXCR3, IC50: 8.2 nM
      99.65%
Reparixin  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
        99.95%
Plerixafor octahydrochloride        
125I-CXCL12-CXCR4, IC50: 44 nM
    99.09%
Navarixin  
Cynomolgus CXCR1, Kd: 41 nM
125I-CXCL8-CXCR1, IC50: 43 nM
Mouse CXCR2, Kd: 0.2 nM
Rat CXCR2, Kd: 0.2 nM
Cynomolgus CXCR2, Kd: 0.08 nM
125I-CXCL8-CXCR2, IC50: 0.97 nM
        98.90%
AZD8797    
125I-IL-8-CXCR2, Ki: 2800 nM (in HEK293S cells)
        99.54%
AZD-5069    
125I-IL-8-CXCR2
        99.91%
TAK-779      
mCXCR3, IC50: 369 nM (in PBMCs)
      99.73%
Motixafortide        
CXCR4, IC50: ~1 nM
    99.88%
SX-682  
CXCR1
CXCR2
        99.67%
ACT-1004-1239          
CXCR7
  99.80%
Mavorixafor trihydrochloride        
125I-SDF-CXCR4, IC50: 13 nM
    99.75%
Baohuoside I        
CXCR4
    99.96%
NUCC-390 dihydrochloride        
CXCR4
    99.05%
ML339            
CXCR6, IC50: 140 nM
99.88%
SCH 546738      
Human CXCR3, Ki: 0.4 nM
      98.71%
IT1t dihydrochloride        
CXCL12/CXCR4, IC50: 2.1 nM
    99.77%
SB-265610    
CXCR2
        ≥99.0%
VUF11207 fumarate          
CXCR7, pKi: 8.1
  98.50%
LY2510924        
125I-SDF-1α-CXCR4, IC50: 79.7 pM
125I-SDF-1α-CXCR4, Ki: 49.5 pM
    99.73%
Danirixin    
CXCL8-CXCR2, IC50: 12.5 nM
        98.88%
CXCR7 antagonist-1          
CXCR7
  99.97%
Reparixin L-lysine salt  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
        99.66%
NBI-74330      
[125I]CXCL10-CXCR3, Ki: 1.5 nM (in CXCR3-CHO cell membranes)
[125I]CXCL11-CXCR3, Ki: 3.2 nM (in CXCR3-CHO cell membranes)
      98.57%
Balixafortide TFA        
CXCR4, IC50: <10 nM
    99.78%
WZ811        
CXCR4, EC50: 0.3 nM
    99.79%
PS372424 hydrochloride      
Human CXCR3
      ≥98.0%
Nicotinamide N-oxide    
CXCR2
        99.85%
Ulocuplumab        
CXCR4
    99.90%
ACT-777991      
CXCR3
      99.86%
TC14012        
CXCR4, IC50: 19.3 nM (antagonist site)
CXCR7, EC50: 350 nM (agonist site)
  99.90%
Elubrixin tosylate    
CXCR2
        99.78%
Ladarixin sodium  
CXCR1
CXCR2
        99.84%
AMD 3465 hexahydrobromide        
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
    ≥98.0%
CXCR2 antagonist 8    
CXCR2
        99.24%
Burixafor hydrobromide        
CXCR4
    ≥98.0%
CXCR2-IN-1    
CXCR2, pIC50: 9.3
        99.47%
MSX-122        
CXCR4/CXCL12, IC50: ~10 nM
    98.92%
CXCR2-IN-2  
CXCR1, IC50: 3.8 μM
CXCR2, IC50: 5.2 nM
        99.52%
CXCR7 antagonist-1 hydrochloride          
CXCR7
  99.66%
CTCE-9908        
CXCR4
    99.47%
SX-517  
CXCR1
CXCR2
        99.88%
ALX 40-4C Trifluoroacetate        
SDF-1-CXCR4, Ki: 1 μM
   
UNBS5162
CXCL
            98.10%
CXCR7 modulator 2          
CXCR7, Ki: 13 nM
  98.71%
CTCE-0214        
SDF-1α-CXCR4
    98.94%
FC131 TFA        
125I-SDF-1-CXCR4, IC50: 4.5 nM
    99.89%
AMD 3465        
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
    99.59%
SCH 563705  
CXCR1, Ki: 3 nM
CXCR1, IC50: 7.3 nM
CXCR2, Ki: 1 nM
CXCR2, IC50: 1.3 nM
Mouse CXCR2, IC50: 5.2 nM
        99.86%
CXCR7 modulator 1          
CXCR7, Ki: 9 nM
  99.50%
ACT-660602      
CXCR3, IC50: 204 nM
      99.86%
SRT3190    
CXCR2
        99.77%
AMG 487 (S-enantiomer)      
CXCR3
      99.94%
AZD8309    
CXCR2, IC50: 4 nM
        99.98%
USL311        
CXCR4
    99.97%
LIT-927        
CXCL12/CXCR4, Ki: 267 nM
    99.86%
MSX-127        
CXCR4
    99.68%
Elubrixin    
CXCR2
       
FC131        
125I-SDF-CXCR4, IC50: 4.5 nM
   
IT1t        
CXCL12/CXCR4, IC50: 2.1 nM
   
KRH-3955 hydrochloride        
SDF-1α-CXCR4, IC50: 0.61 nM
   
PS372424      
Human CXCR3
     
ALX 40-4C        
SDF-1-CXCR4, Ki: 1 μM
   
MSX-130        
CXCR4
    98.00%
Mavorixafor        
125I-SDF-CXCR4, IC50: 13 nM
   
NUCC-390        
CXCR4
    98.40%
SRT3109    
CXCR2, pIC50: 8.2
        99.82%
Mavorixafor hydrochloride        
125I-CXCL12-CXCR4, IC50: 13 nM
   
Balixafortide        
CXCR4, IC50: <10 nM
   
CXCR4-IN-3        
CXCR4, IC50: 3.2 nM
   
CXCR3 antagonist 1      
CXCR3, IC50: 0.06 μM
     
CXCR4 antagonist 3        
CXCR4, IC50: 11 nM
   
CXCR2 antagonist 6    
CXCR2, IC50: 0.43 μM
       
CXCR4 antagonist 1        
CXCR4
   
AZ10397767    
CXCR2, IC50: 1 nM
       
Peptide R        
CXCR4
   
ICT5040        
CXCR4, IC50: 3.8 μM
   
CXCR2 antagonist 7    
CXCR2, IC50: 0.044 μM
       
TC14012 TFA        
CXCR4, IC50: 19.3 nM (antagonist site)
CXCR7, EC50: 350 nM (agonist site)
 
CXCR4 antagonist 4        
CXCR4, IC50: 24 nM
   
Corydalmine    
CXCR2
       
CXCR4 antagonist 8        
CXCR4, IC50: 57 nM
   
CXCR4 modulator-2        
CXCR4, IC50: 1.25 nM
   
CXCR4 antagonist 6        
CXCR4, IC50: 79 nM
   
CXCR2 antagonist 4    
CXCR2, IC50: 0.13 μM
       
CXCR4 antagonist 7        
CXCR4/CXCL12, IC50: 9.3 nM
   
CXCR4 antagonist 5        
CXCR4, IC50: 8.8 nM
   
CTCE-9908 TFA        
CXCR4
   
HF50731        
CXCR4, IC50: 19.8 nM
   
RCP168        
CXCR4, IC50: 5 nM
   
EPI-X4        
CXCR4, IC50: 8.6 μM
   
CXCR4 modulator-1        
CXCR4, EC50: 100 nM
   
TIQ-15        
CXCR4, IC50: 6 nM
   
CCX662          
CXCR7
 
BAM-12P          
CXCR7, EC50: 175 nM
 
CXCR2 antagonist 5    
CXCR2, IC50: 0.013 μM
       
Nicotinamide N-oxide (Standard)    
CXCR2
       
Hit 14        
12G5 mAb-CXCR4, IC50: 254 nM
   
CXCR4 antagonist 9        
CXCR4, IC50: 15 nM
   
CXCR4 antagonist 10        
CXCR4, IC50: 7.8 nM
   
Ac-Pro-Gly-Pro-OH    
CXCR2
       
VUF11207          
CXCR7, pKi: 8.1
 
KRH-1636        
CXCR4
   
ATI-2341        
CXCR4, EC50: 194 nM (in CCRF-CEM cells)
   
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》